|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.930 USD | +2.08% |
|
-5.76% | -86.38% |
| Market Cap | 22Cr 19Cr 18Cr 17Cr 31Cr 2.13TCr 32Cr 212.1Cr 83Cr 1.06TCr 84Cr 82Cr 3.55TCr | P/E 2026 * |
-2.72x | P/E 2027 * | -2.76x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 17Cr 31Cr 2.13TCr 32Cr 212.1Cr 83Cr 1.06TCr 84Cr 82Cr 3.55TCr | EV / Sales 2026 * |
3.44x | EV / Sales 2027 * | 4.61x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | +2.08% | ||
| 1 week | -5.76% | ||
| Current month | +2.08% | ||
| 1 month | -80.93% | ||
| 3 months | -87.68% | ||
| 6 months | -83.76% | ||
| Current year | -86.38% |
| 1 week | 3.73 |  | 4.7 |
| 1 month | 2.96 | | 21.53 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/04/26 | Fiscal year | Director | 22,587 | 0.0393% | ||
| 05/01/26 | Free | General Counsel | 45,000 | 0.0827% | ||
| 05/01/26 | Free | Director | 15,500 | 0.0285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | -5.76% | -49.71% | -34.93% | 22Cr | |
| -0.70% | +24.68% | +76.72% | +103.05% | 7.09TCr | |
| -2.35% | +3.71% | +31.77% | +63.89% | 5.54TCr | |
| -1.62% | +34.25% | +17.43% | +491.04% | 2.94TCr | |
| -0.30% | +18.51% | +56.61% | +4.86% | 2.41TCr | |
| 0.00% | +1.59% | -15.06% | -13.21% | 2.33TCr | |
| +0.05% | +6.12% | +46.81% | -21.81% | 1.84TCr | |
| +9.77% | +25.32% | +252.40% | +442.16% | 1.7TCr | |
| 0.00% | +10.84% | +31.14% | +628.97% | 1.61TCr | |
| -3.08% | -8.34% | +37.21% | +138.52% | 1.31TCr | |
| Average | +0.38% | +298.83% | +48.53% | +180.25% | 2.68TCr | |
| Weighted average by Cap. | -0.40% | +316.01% | +55.43% | +164.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.48Cr 5.61Cr 5.25Cr 4.79Cr 9.02Cr 617.65Cr 9.17Cr 62Cr 24Cr 309.15Cr 24Cr 24Cr 1.03TCr | 4.84Cr 4.19Cr 3.92Cr 3.58Cr 6.74Cr 461.41Cr 6.85Cr 46Cr 18Cr 230.95Cr 18Cr 18Cr 770.49Cr |
| Net income | -8.24Cr -7.14Cr -6.68Cr -6.1Cr -11Cr -785.58Cr -12Cr -78Cr -31Cr -393.2Cr -31Cr -30Cr -1.31TCr | -8.37Cr -7.26Cr -6.79Cr -6.2Cr -12Cr -798.58Cr -12Cr -80Cr -31Cr -399.71Cr -31Cr -31Cr -1.33TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $3.930 | +2.08% | 32,76,128 |
| 10/26/10 | $3.850 | -5.87% | 30,88,697 |
| 07/26/07 | $4.090 | -2.15% | 36,18,170 |
| 06/26/06 | $4.180 | +6.36% | 32,12,514 |
| 05/26/05 | $3.930 | -5.76% | 36,78,169 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
